Zobrazeno 1 - 10 of 138 pro vyhledávání: '"Melarkode R"'
1
Akademický článek
Analytical similarity assessment of MYL-1402O to reference Bevacizumab.
Autor: Goyal P; Biologics R&D, Viatris Inc, Canonsburg, PA, USA., Vats B; Biologics R&D, Viatris Inc, Hyderabad, India., Subbarao M; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Honnappa CG; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Kabadi P; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Rohil S; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Bera A; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Mehta GR; Biologics R&D, Viatris Inc, Hyderabad, India., Pai H; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Adhikari L; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Tagore R; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Sharma S; Biologics R&D, Viatris Inc, Hyderabad, India., Venkatachala R; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Nair P; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Annegowda S; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Sahu A; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Trivedi S; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Shastri N; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Gokhale Y; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Thomas R; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Thakur A; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Mohan D; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Rao K U; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Melarkode R; Biocon Research Lab, Biocon Biologics Limited, Bengaluru, India., Ullanat R; Biologics R&D, Viatris Inc, Hyderabad, India.
Publikováno v: Expert opinion on biological therapy [Expert Opin Biol Ther] 2022 Feb; Vol. 22 (2), pp. 271-298. Date of Electronic Publication: 2021 Oct 13.
Zobrazit plný text záznamu
2
Akademický článek
CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
Autor: Nair, P.1, Melarkode, R.1, Rajkumar, D.1, Montero, E.2 enrique@cim.sld.cu
Publikováno v: Clinical & Experimental Immunology. Oct2010, Vol. 162 Issue 1, p116-130. 15p. 1 Color Photograph, 1 Chart, 4 Graphs.
Zobrazit plný text záznamu
3
Akademický článek
Physicochemical and functional characterization of trastuzumab-dkst, a trastuzumab biosimilar.
Autor: Goyal P; Viatris, Inc., 1000 Mylan Boulevard, Canonsburg, PA 15317, USA., Iyer J; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Adhikary L; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Vats B; Viatris Inc, Plot No 564/A/22, Road No 92, Jubilee Hills, Hyderabad, 500034, India., Kabadi P; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Pai H; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Ranayhossaini D; Viatris, Inc., 1000 Mylan Boulevard, Canonsburg, PA 15317, USA., Gouda S; Viatris Inc, Plot No 564/A/22, Road No 92, Jubilee Hills, Hyderabad, 500034, India., Subbarao M; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Mehta G; Viatris Inc, Plot No 564/A/22, Road No 92, Jubilee Hills, Hyderabad, 500034, India., Saha A; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Bera A; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Sahu A; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Kaur M; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Singh A; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Marwah A; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Reddy Moole PK; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Smith J; Viatris, Inc., 1000 Mylan Boulevard, Canonsburg, PA 15317, USA., Melarkode R; Biocon Biologics Limited, Biocon Special Economic Zone, Plot No. 2&3, Phase IV-B.I.A, Bommasandra-Jigani Link Road, Bangalore, 560099, India., Ullanat R; Viatris Inc, Plot No 564/A/22, Road No 92, Jubilee Hills, Hyderabad, 500034, India.
Publikováno v: Future medicinal chemistry [Future Med Chem] 2021 Sep; Vol. 13 (18), pp. 1531-1557. Date of Electronic Publication: 2021 Jul 22.
Zobrazit plný text záznamu
4
Akademický článek
Physicochemical and functional characterization of MYL-1501D, a proposed biosimilar to insulin glargine.
Autor: Goyal P; Viatris Inc, Canonsburg, PA, United States of America., Pai HV; Biocon Research Limited, Bangalore, India., Kodali P; Biocon Research Limited, Bangalore, India., Vats B; Viatris Inc, Hyderabad, India., Vajpai N; Biocon Research Limited, Bangalore, India., Annegowda S; Biocon Research Limited, Bangalore, India., Mane K; Biocon Research Limited, Bangalore, India., Mohan S; Biocon Research Limited, Bangalore, India., Saxena S; Biocon Research Limited, Bangalore, India., Veerabhadraia AB; Biocon Research Limited, Bangalore, India., Palande M; Biocon Research Limited, Bangalore, India., Nair PS; Biocon Research Limited, Bangalore, India., More DC; Biocon Research Limited, Bangalore, India., Karudumpa UR; Biocon Research Limited, Bangalore, India., Jyothirmai K; Biocon Research Limited, Bangalore, India., Bhattacharya A; Biocon Research Limited, Bangalore, India., Almeida F; Biocon Research Limited, Bangalore, India., Khyade SG; Biocon Research Limited, Bangalore, India., Gouda S; Viatris Inc, Hyderabad, India., Ranayhossaini DJ; Viatris Inc, Canonsburg, PA, United States of America., Moole PR; Biocon Research Limited, Bangalore, India., Smith JP; Viatris Inc, Canonsburg, PA, United States of America., Barve A; Viatris Inc, Canonsburg, PA, United States of America., Melarkode R; Biocon Research Limited, Bangalore, India., Ullanat R; Viatris Inc, Hyderabad, India.
Publikováno v: PloS one [PLoS One] 2021 Jun 16; Vol. 16 (6), pp. e0253168. Date of Electronic Publication: 2021 Jun 16 (Print Publication: 2021).
Zobrazit plný text záznamu
5
Akademický článek
Correction: T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.
Autor: Bughani U, Saha A, Kuriakose A, Nair R, Sadashivarao RB, Venkataraman R, Patel S, Tushar Deshchougule A, Satish KS, Montero E, Pai HV, Palanivelu DV, Melarkode R, Nair P
Publikováno v: PloS one [PLoS One] 2018 Jan 30; Vol. 13 (1), pp. e0192335. Date of Electronic Publication: 2018 Jan 30 (Print Publication: 2018).
Zobrazit plný text záznamu
6
Akademický článek
Development and validation of a cell based assay for the detection of neutralizing antibodies against recombinant insulins.
Autor: Chatterjee S; Biocon Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A. Bommasandra-Jigani Link Road, Bangalore 560099, India. Electronic address: sanjuktahona@yahoo.com., Vashishta L; Biocon Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A. Bommasandra-Jigani Link Road, Bangalore 560099, India., Waichale VS; Biocon Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A. Bommasandra-Jigani Link Road, Bangalore 560099, India., Nayak VG; Biocon Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A. Bommasandra-Jigani Link Road, Bangalore 560099, India., Melarkode R; Biocon Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A. Bommasandra-Jigani Link Road, Bangalore 560099, India., Donnelly CM; Mylan Pharmaceuticals, 3711 Collins Ferry Road, Morgantown, WV 26505, USA., Vallano PT; Mylan Pharmaceuticals, 3711 Collins Ferry Road, Morgantown, WV 26505, USA., Chirmule N; Biocon Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A. Bommasandra-Jigani Link Road, Bangalore 560099, India., Sengupta N; Biocon Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A. Bommasandra-Jigani Link Road, Bangalore 560099, India. Electronic address: Nilanjan.Sengupta@biocon.com.
Publikováno v: Journal of immunological methods [J Immunol Methods] 2018 Jan; Vol. 452, pp. 53-62. Date of Electronic Publication: 2017 Sep 19.
Zobrazit plný text záznamu
7
Akademický článek
T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.
Autor: Bughani U; Research and Development, Biocon Research Limited, Bangalore, India., Saha A; Research and Development, Biocon Research Limited, Bangalore, India., Kuriakose A; Research and Development, Biocon Research Limited, Bangalore, India., Nair R; Research and Development, Biocon Research Limited, Bangalore, India., Sadashivarao RB; Research and Development, Biocon Research Limited, Bangalore, India., Venkataraman R; Research and Development, Biocon Research Limited, Bangalore, India., Patel S; Research and Development, Biocon Research Limited, Bangalore, India., Deshchougule AT; Research and Development, Biocon Research Limited, Bangalore, India., S SK; Research and Development, Biocon Research Limited, Bangalore, India., Montero E; Research and Development, Biocon Research Limited, Bangalore, India., Pai HV; Research and Development, Biocon Research Limited, Bangalore, India., Palanivelu DV; Research and Development, Biocon Research Limited, Bangalore, India., Melarkode R; Research and Development, Biocon Research Limited, Bangalore, India., Nair P; Research and Development, Biocon Research Limited, Bangalore, India.
Publikováno v: PloS one [PLoS One] 2017 Jul 03; Vol. 12 (7), pp. e0180088. Date of Electronic Publication: 2017 Jul 03 (Print Publication: 2017).
Zobrazit plný text záznamu
8
Akademický článek
Development and validation of an electrochemiluminescent ELISA for quantitation of oral insulin tregopil in diabetes mellitus serum.
Autor: Ramaswamy SG; Research and Development, Biocon Research Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A., Bommasandra-Jigani Link Road, Bangalore 560099, India., Nayak VG; Research and Development, Biocon Research Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A., Bommasandra-Jigani Link Road, Bangalore 560099, India., Jha SK; Research and Development, Biocon Research Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A., Bommasandra-Jigani Link Road, Bangalore 560099, India., Hegde V; Research and Development, Biocon Research Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A., Bommasandra-Jigani Link Road, Bangalore 560099, India., Waichale VS; Research and Development, Biocon Research Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A., Bommasandra-Jigani Link Road, Bangalore 560099, India., Melarkode R; Research and Development, Biocon Research Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A., Bommasandra-Jigani Link Road, Bangalore 560099, India., Chirmule N; Research and Development, Biocon Research Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A., Bommasandra-Jigani Link Road, Bangalore 560099, India., Rao AU; Research and Development, Biocon Research Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A., Bommasandra-Jigani Link Road, Bangalore 560099, India., Sengupta N; Research and Development, Biocon Research Limited, Biocon Special Economic Zone, Plot Nos. 2 & 3, Phase IV-B.I.A., Bommasandra-Jigani Link Road, Bangalore 560099, India.
Publikováno v: Bioanalysis [Bioanalysis] 2017 Jul; Vol. 9 (13), pp. 975-986. Date of Electronic Publication: 2017 Jul 10.
Zobrazit plný text záznamu
9
Akademický článek
CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies.
Autor: Aragón-Serrano, Lucía1 (AUTHOR) laragose79@alumnes.ub.edu, Carrillo-Serradell, Laura1 (AUTHOR) lcarrillo@recerca.clinic.cat, Planells-Romeo, Violeta1 (AUTHOR) planellsi@recerca.clinic.cat, Isamat, Marcos2 (AUTHOR) misamat@sepsia.com, Velasco-de Andrés, María1 (AUTHOR) mvelascod@recerca.clinic.cat, Lozano, Francisco1,3,4 (AUTHOR) flozano@clinic.cat
Publikováno v: International Journal of Molecular Sciences. Dec2023, Vol. 24 Issue 24, p17510. 13p.
Zobrazit plný text záznamu
10
Akademický článek
EGFR targeting monoclonal antibody combines with an mTOR inhibitor and potentiates tumor inhibition by acting on complementary signaling hubs.
Autor: James R; Biocon Ltd., R&D, Drug Development Group Bangalore, 560100, India., Vishwakarma S, Chivukula IV, Basavaraj C, Melarkode R, Montero E, Nair P
Publikováno v: Cancer medicine [Cancer Med] 2012 Oct; Vol. 1 (2), pp. 114-27. Date of Electronic Publication: 2012 Aug 01.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje